Fulgent Genetics, Inc. (FLGT)
NASDAQ: FLGT · Real-Time Price · USD
19.68
+0.08 (0.41%)
Jun 27, 2025, 4:00 PM - Market closed
Fulgent Genetics Market Cap
Fulgent Genetics has a market cap or net worth of $599.13 million as of June 27, 2025. Its market cap has decreased by -1.72% in one year.
Market Cap
599.13M
Enterprise Value
-207.02M
1-Year Change
-1.72%
Ranking
Category
Stock Price
$19.68
Market Cap Chart
Since September 29, 2016, Fulgent Genetics's market cap has increased from $156.50M to $599.13M, an increase of 282.83%. That is a compound annual growth rate of 16.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 26, 2025 | 596.70M | 5.63% |
| Dec 31, 2024 | 564.90M | -34.06% |
| Dec 29, 2023 | 856.70M | -2.28% |
| Dec 30, 2022 | 876.70M | -70.78% |
| Dec 31, 2021 | 3.00B | 137.27% |
| Dec 31, 2020 | 1.26B | 423.90% |
| Dec 31, 2019 | 241.40M | 321.29% |
| Dec 31, 2018 | 57.30M | -26.63% |
| Dec 29, 2017 | 78.10M | -61.81% |
| Dec 30, 2016 | 204.50M | 30.67% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 711.06B |
| Johnson & Johnson | 365.06B |
| AbbVie | 329.06B |
| Novo Nordisk | 301.06B |
| UnitedHealth Group | 273.68B |
| Novartis AG | 235.02B |
| Abbott Laboratories | 231.35B |
| AstraZeneca | 216.45B |